docetaxel anhydrous has been researched along with cynaropicrin in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cynaropicrin) | Trials (cynaropicrin) | Recent Studies (post-2010) (cynaropicrin) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 53 | 0 | 41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butturini, E; Carcereri de Prati, A; Cavalieri, E; Chiavegato, G; Darra, E; Mariotto, S; Rigo, A | 1 |
1 other study(ies) available for docetaxel anhydrous and cynaropicrin
Article | Year |
---|---|
Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cytotoxins; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Glutathione; Humans; Inhibitor of Apoptosis Proteins; Lactones; Oxidative Stress; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Survivin; Taxoids | 2013 |